HIV retesting and risk behaviors among high-risk, HIV-uninfected adults in Uganda
Taylor & Francis Group
Authors
Marson K, Ndyabakira A, Kwarisiima D, Camlin CS, Kamya MR, Havlir D, Thirumurthy H, Chamie G.
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members
Journal of Clinical OncologyOctober 2, 2024 -
Design and Rationale of Penn Medicine Healthy Heart, a Randomized Trial of Effectiveness of a Centrally Organized Approach to Blood Pressure and Cholesterol Improvement Among Patients at Elevated Risk of Atherosclerotic Cardiovascular Disease
American Heart JournalSeptember 27, 2024 -
Using Behavioral Science to Improve Cardiovascular Health
AHA JournalsSeptember 3, 2024 -
Behaviourally-informed two-way text messaging to improve return to HIV care in South Africa: evidence from a randomised controlled trial
MedRxivAugust 18, 2024 -
Effectiveness of Using Additional HIV Self-Test Kits as an Incentive to Increase HIV Testing Within Assisted Partner Services
JAIDSAugust 15, 2024 -
"What choice do we have?" Reactive and proactive decision-making for aging in place with dementia
AGSAugust 14, 2024 -
Evaluation of four interventions using behavioural economics insights to increase demand for voluntary medical male circumcision in South Africa through the MoyaApp: A quasi-experimental study
JAIDSAugust 9, 2024 -
Applying behavioural economics principles to increase demand for free HIV testing services at private doctor-led clinics in Johannesburg, South Africa: A randomised controlled trial
PLOS Global Public HealthAugust 6, 2024 -
Willingness to trade-off years of life for an HIV cure - an experimental exploration of affective forecasting
AIDS Research and TherapyAugust 6, 2024 -
Advancing Equity In Kidney Transplantation Through The Increasing Organ Transplant Access Model
Health AffairsAugust 1, 2024 -
Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton's tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline setting
JMCPJuly 24, 2024 -
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial
ASCOJuly 3, 2024